评估神经肌肉阻塞剂在经过快速序列输管治疗的骨髓灰质炎患者的使用情况
Nick B Polito1, Shawn E Fellows2, Andrew S Knapp3
1Emergency Medicine Clinical Pharmacist, Department of Pharmacy, Highland Hospital, 1000 South Ave, Rochester, New York 14620, USA.
The American journal of emergency medicine
|February 4, 2026
概括
神经肌肉阻断剂 (NMBA) 剂量在经过快速序列输管 (RSI) 在手术室 (OR) 外的肌肉骨髓衰竭 (MG) 患者中往往缺乏调整. 虽然没有观察到不充分的,但在某些情况下出现了长时间的,这凸显了需要进一步研究的需要.
科学领域:
- 麻醉学 麻醉学
- 神经学 神经学
- 临界护理医学 临界护理医学
背景情况:
- 肌痛性骨髓灰质炎 (MG) 对神经肌肉阻断剂 (NMBA) 的使用提出了独特的挑战,原因是患者敏感性发生变化.
- 标准的NMBA剂量协议可能不适用于MG患者,特别是在手术室 (OR) 外.
研究的目的:
- 描述NMBAs在骨髓灰质炎患者的使用和作用,这些患者在手术室外接受快速序列输管 (RSI).
- 为了评估NMBA剂量调整和这个特定人群中的患者结果.
主要方法:
- 追溯性,观察性,多中心研究.
- 分析了44例MG患者在OR外经历RSI的病例 (2011年1月至2023年9月).
- 收集患者人口统计数据,NMBA类型和剂量以及输管后监测.
主要成果:
- 大多数患者 (75%) 没有接受NMBA剂量调整.
- 没有报告过不充分的病例.
- 在11.4%的病例中观察到长时间的,输管后神经肌肉评估有限.
结论:
- 在MG患者接受OR外RSI的NMBA剂量调整的必要性尚不清楚.
- 临床医生必须考虑MG患者可能出现不可预测的NMBA反应.
- 及时监测,镇静和止痛药对于这些患者来说,在直后输管期至关重要.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.0K
Myasthenia Gravis: Diagnostic Tests
2.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
800
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
800
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.9K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
982
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
982
Endotracheal Intubation I: Procedure
8.6K
Endotracheal or ET intubation is a critical medical procedure used to secure a patient's airway, often in acute respiratory distress, apnea, upper airway obstruction, ineffective clearance of secretions, high risk for aspiration, or during general anesthesia.
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...
8.6K


